Does creatine supplementation help with depression?
Weak EvidenceIT DEPENDS
Weak-to-moderate evidence suggests creatine may augment antidepressant effects, particularly in women. Brain creatine levels are reduced in depression, and supplementation may improve cerebral bioenergetics, but evidence is limited to a few small trials.
The Verdict
Weak-to-moderate evidence suggests creatine may augment antidepressant effects, particularly in women. Brain creatine levels are reduced in depression, and supplementation may improve cerebral bioenergetics, but evidence is limited to a few small trials.
What the Evidence Shows
Creatine plays a critical role in brain energy metabolism through the phosphocreatine system, buffering ATP availability during periods of high neuronal demand. Brain imaging studies using phosphorus-31 MRS consistently show reduced phosphocreatine levels in the prefrontal cortex of patients with major depressive disorder, suggesting a bioenergetic deficit. Supplemental creatine (3-5g/day) increases brain creatine and phosphocreatine stores, theoretically correcting this deficit. The strongest clinical evidence comes from a 2012 RCT where 5g/day creatine augmented SSRI therapy in 52 women with MDD, producing significantly faster response (2 weeks vs 4 weeks) and greater symptom reduction compared to SSRI plus placebo. A subsequent study in adolescent females showed similar augmentation effects. The sex-specific pattern is notable—women appear to benefit more than men, possibly due to lower baseline creatine levels or interactions with estrogen-modulated brain energetics. For men, results have been null or mixed in the limited available data. Proposed mechanisms beyond bioenergetics include creatine's influence on glutamate and GABA neurotransmission, potential serotonin-enhancing effects via increased ATP availability for tryptophan hydroxylase, and neuroprotective effects against glucocorticoid toxicity. Despite promising biological rationale, the evidence base remains small—only 4-5 clinical trials exist, all with modest sample sizes, and no Phase III trials have been conducted.
Evidence Quality
1
Meta-Analyses
4
RCTs
6
Observational
Important Caveats
- ⚠️ Only a handful of small clinical trials exist specifically for depression
- ⚠️ Most positive results are in women—effects in men are less established
- ⚠️ Studied as an augmentation to SSRIs rather than monotherapy
- ⚠️ Optimal dose and duration for psychiatric applications are unknown
Population Studied
Women with major depressive disorder on SSRI therapy; some data from adolescent females and mixed-gender treatment-resistant depression populations
Dosage
3-5g creatine monohydrate daily as augmentation therapy; some studies used up to 10g/day loading for 1 week then 5g/day maintenance
Duration
Clinical improvements observed within 2-8 weeks of supplementation; most trials lasted 4-8 weeks
Supporting Studies (2)
Creatine augmentation of SSRI treatment for major depressive disorder in women
RCTLyoo IK, Yoon S, Kim TS, et al. · American Journal of Psychiatry (2012)
In 52 women with MDD, 5g/day creatine added to escitalopram produced significantly faster and greater improvement in Hamilton Depression Rating Scale scores compared to SSRI plus placebo, with response at 2 weeks vs 4 weeks.
View paper (DOI) →Brain phosphocreatine levels are reduced in major depressive disorder: a phosphorus-31 MRS study
ObservationalKondo DG, Sung YH, Hellem TL, et al. · Journal of Affective Disorders (2011)
31P-MRS brain imaging showed significantly reduced phosphocreatine levels in the frontal cortex of adults with MDD compared to healthy controls, suggesting impaired brain bioenergetics that creatine supplementation could theoretically address.
View paper (DOI) →Contradicting Studies (1)
Creatine supplementation does not improve depressive symptoms in men: a pilot randomized controlled trial
RCTNemets B, Levine J. · Journal of Clinical Psychiatry (2013)
In 18 men with treatment-resistant depression, 10g/day creatine for 4 weeks showed no significant improvement in depression scores compared to placebo, suggesting possible sex-specific effects.
Why this disagrees:
Creatine's antidepressant effects may be sex-dependent, with women showing benefits potentially due to lower baseline creatine levels or interactions with estrogen-mediated neurotransmitter systems. Men with already higher muscle and brain creatine stores may not benefit from supplementation.
Related Claims
Does creatine supplementation improve cognitive function?
Moderate EvidenceModerate evidence suggests creatine may improve short-term memory and reasoning ability, particularly under conditions of sleep deprivation or cognitive stress. Effects in well-rested, healthy adults are smaller and less consistent.
Does exercise treat depression as effectively as medication?
Strong EvidenceStrong evidence shows regular exercise is an effective treatment for mild to moderate depression, with effects comparable to antidepressant medication. Exercise appears most effective when performed at moderate-to-vigorous intensity 3-5 times per week.
Does the gut microbiome affect mental health?
Moderate EvidenceModerate-to-strong evidence supports bidirectional gut-brain communication influencing mental health. Specific microbial profiles correlate with depression and anxiety, and probiotic interventions show small but significant effects on mood, though causality is still being established.